Skip to main content

Biotechnology

BXP Completes Waltham R&D Facility

Published 7/8/2024

BXP recently completed a 113,000-rsf innovation hub in Waltham, Mass. Designed by TRIA, 103 CityPoint aims to reshape corporate culture for science and technology tenants, energizing its workforce and accelerating growth. The flexible flour-story structure provides 80 percent laboratory and office space, with 20 percent accommodating a double-height cGMP manufacturing area spanning approximately 25,000 sf.

Read More

The Davis Companies Completes Cambridge Research Facility

Published 7/2/2024

The Davis Companies and Invesco Real Estate completed construction in June of 2024 on a 215,000-sf research facility in Cambridge. Designed by Jacobs, 101 Smith Place is the third structure in a new life sciences cluster called The Quad and offers 161,616 rsf of Class A lab and office space. Features include:

Read More

Merck Constructs Quality Control Facility

Published 6/27/2024

Merck is expanding its Darmstadt headquarters campus with the construction of a $66 million quality control facility for MilliporeSigma, the company’s life science business. Spanning approximately 105,000 sf, the four-story building will provide GMP labs and cleanrooms for the testing of medicines and biological agents. The flexible structure is designed to enhance operational efficiencies and will bring 135 employees from different departments together in one collaborative location.

Read More

University of Tennessee’s Agriculture & Natural Resources Building (ANRB) Creates Living Research Environment

Published 6/19/2024

The $93 million Agriculture & Natural Resources Building (ANRB) at the University of Tennessee, Knoxville provides enhanced research, education, and collaboration with advanced technology, specialized labs, flexible classrooms, a large commons area, a 500-seat auditorium, lecture halls, seamless connections to nearby academic buildings, and a welcoming pedestrian plaza to engage the community. A biophilic design connects students, faculty, and staff with nature through the use of clerestory windows and a green roof that acts as an exterior living room with research gardens.  

Read More

WACKER Opens mRNA Competence Center

Published 6/19/2024

WACKER opened the mRNA Competence Center in June of 2024 in Halle an der Saale, Germany. Representing an investment of over €100 million, the next-generation facility enables the large-scale production of active ingredients based on messenger ribonucleic acid (mRNA). The building spans a total floor area of 79,653 sf and accommodates four new lines supported by advanced infrastructure, including 17,222 sf of glass-enclosed cleanroom space for bioprocessing under controlled conditions. 

Read More

Sanofi Opens Vaccine Production Facility in Toronto

Published 6/11/2024

Sanofi opened a 20,000-sf biomanufacturing center in May of 2024 in Toronto. Producing adult and pediatric vaccines for pertussis, diphtheria, and tetanus, the project significantly increases capacity to meet growing demand in Canada and around the world. The next-generation facility features advanced bioprocessing suites supported by highly efficient infrastructure. Commissioning is currently under way, with full operations slated to commence in mid-2025.

Read More

University of Delaware Breaks Ground on Biomanufacturing Center

Published 5/1/2024

The University of Delaware broke ground in April of 2024 on the Securing American Biomanufacturing Research and Education (SABRE) Center. The $150 million facility will enhance the R&D capabilities of the adjacent National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) while driving the creation of a skilled workforce. Serving as a living laboratory for the formulation of best practices, the 70,000-sf building is envisioned as a place to scale up and mature new production methods.

Read More

Delancey Plans London Innovation Hub

Published 4/29/2024

Delancey is planning to construct a £400 million innovation hub in London's Knowledge Quarter. Designed by Gardiner & Theobald and KPF, the 194,000-sf structure will offer 130,000 sf of leasable research space for biomedical companies, technology firms, and start-up enterprises. The highly adaptable facility will feature next-generation laboratories, traditional and open offices, a maker space, and a community event venue. Typical floors will have access to an amenity terrace with a range of interactive settings.

Read More

Fujifilm Diosynth Biotechnologies Constructs Holly Springs Campus

Published 4/24/2024

FUJIFILM Diosynth Biotechnologies is constructing a $3.2 billion pharmaceutical campus in Holly Springs, N.C. Integrating sophisticated automation technologies, the multi-building development will enable large-scale cell culture manufacturing for the creation of bulk drug substances. Ground was broken in October of 2021 on the first phase, a $2 billion production center slated for completion in early 2025. A subsequent investment of $1.2 billion will establish an additional 425,000-sf plant that will begin operations in 2028.

Read More

Novo Nordisk Partners with Alexandria Real Estate Equities on Waltham R&D Facility

Published 4/15/2024

Novo Nordisk has executed a long-term, full-building lease for a 165,940-rsf property at the Alexandria Center for Life Science in Waltham, Mass. Located at 60 Sylvan Road, the research facility is being redeveloped to provide next-generation environments for biomedical discovery. Neighborhoods of labs, offices, and collaboration spaces will foster interaction between investigators to accelerate the discovery and commercialization of new therapies. Occupancy is expected in 2025.

Read More

Lonza Acquires Vacaville Pharmaceutical Campus

Published 4/10/2024

Lonza is investing $1.2 billion to purchase a pharmaceutical manufacturing campus in Vacaville, Calif. Presently occupied by Genentech, a subsidiary of Roche, the 427,000-sf complex provides a total bioreactor capacity of approximately 330 liters. Lonza is offering employment to 750 personnel at the site, which will continue to supply its current products at a committed volume of 30 percent throughout 2025.

Read More

Pfizer Partners with Breakthrough Properties on San Diego Oncology Center

Published 4/3/2024

Pfizer has signed a 15-year lease for 230,000 sf of Class A research space in San Diego to accommodate its growing oncology division. The global pharmaceutical manufacturer will occupy two of the three buildings that are currently under construction at Breakthrough Properties' Torrey View campus. Leading-edge wet labs will advance the creation of novel therapies, accompanied by flexible offices and collaboration spaces.

Read More

Phase 3 Real Estate Partners Opens Life Sciences Complex

Published 3/29/2024

Phase 3 Real Estate Partners and Bain Capital completed construction in February of 2024 on Genesis Marina, a waterfront life sciences campus in Brisbane, Calif. Offering floor plates of up to 42,000 sf, the three-building complex provides over 560,000 rsf of Class A laboratory and office space. Every research suite is equipped with a modular benching system that is pre-plumbed and pre-wired for fast installation and effortless reconfiguration.

Read More

Oxford Properties and Pioneer Group Create London Life Science Center

Published 3/19/2024

Oxford Properties is transforming Victoria House in central London into a vibrant destination for biomedical research. Developed in partnership with Pioneer Group, the £70 million project involves the conversion of 220,000 sf of the building's 300,000-sf internal area to provide sophisticated wet labs and write-up areas.

Read More